double-activity substituted [(5h-pyrrol [2,1-c] [1,4] benzodiazepin-11-yl) piperazin-1-yl] -2,2-dimethylpropanoic acid compounds h1 inverse agonists / 5-antagonists -ht2a.
- 专利权人:
- ELI LILLY AND COMPANY
- 发明人:
- ADAM JAN SANDERSON,ANDREW JAMES LEDGARD,ANNE MARIE CAMP,DAVID ANDREW COATES,PETER THADDEUS GALLAGHER
- 申请号：
- BR112013019996
- 公开号：
- BR112013019996A2
- 申请日:
- 2012.01.25
- 申请国别(地区):
- BR
- 年份:
- 2018
- 代理人:
- 摘要：
- A dual H1/5-HT2A receptor antagonist of the formula: its uses, and methods for its preparation are described.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- SUBSTITUTED [(5H-pyrrolo [2,1-c] [1,4] benzodiazepin-11-yl) -piperazin-1-yl] -2,2-DIMETHYLPROPANSYREFORBINDELSER as double acting H1-inverse agonists / 5-HT 2A antagonists
- תכשירים ושיטות לאפנון התפתחות@כלי@דם
- COMPOSITIONS AND METHODS COMPRISING AN EGFL7 ANTAGONIST FOR MODULATING VASCULAR DEVELOPMENT
- Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity H1 inverse agonists/5-HT2A antagonists
- SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
